Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.11 - $2.78 $5,697 - $14,269
-5,133 Reduced 97.38%
138 $0
Q2 2022

Aug 08, 2022

BUY
$2.06 - $4.25 $206 - $425
100 Added 1.93%
5,271 $14,000
Q1 2022

May 10, 2022

BUY
$3.3 - $5.44 $9 - $16
3 Added 0.06%
5,171 $22,000
Q4 2021

Feb 11, 2022

SELL
$4.56 - $10.56 $136 - $316
-30 Reduced 0.58%
5,168 $27,000
Q2 2021

Aug 09, 2021

BUY
$9.02 - $12.93 $31,497 - $45,151
3,492 Added 204.69%
5,198 $54,000
Q1 2021

Apr 28, 2021

BUY
$10.56 - $13.94 $18,015 - $23,781
1,706 New
1,706 $19,000
Q4 2020

Feb 09, 2021

SELL
$9.44 - $13.3 $16,104 - $22,689
-1,706 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$9.3 - $25.16 $7,505 - $20,304
-807 Reduced 32.11%
1,706 $15,000
Q2 2020

Aug 11, 2020

SELL
$15.99 - $22.88 $13,719 - $19,631
-858 Reduced 25.45%
2,513 $58,000
Q1 2020

May 15, 2020

BUY
$9.76 - $23.8 $32,900 - $80,229
3,371 New
3,371 $67,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.